Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 7,155 | 8,015 | 11,231 | 10,544 | 11,818 |
| Operating Income | -7,155 | -8,015 | -11,231 | -10,544 | -11,818 |
| Interest Expense | 0 | 0 | 0 | 268 | 303 |
| Other Income | 29 | 449 | -999 | 64 | 0 |
| Pre-tax Income | -7,126 | -7,566 | -12,230 | -10,749 | -12,122 |
| Net Income Continuous | -7,126 | -7,566 | -12,230 | -10,749 | -12,122 |
| Net Income | $-7,126 | $-7,566 | $-12,230 | $-10,749 | $-12,122 |
| EPS Basic Total Ops | -46.12 | -66.29 | -118.17 | -165.73 | -269.50 |
| EPS Basic Continuous Ops | -46.06 | -65.68 | -118.30 | -165.88 | -269.33 |
| EPS Diluted Total Ops | -46.12 | -66.29 | -129.70 | -165.73 | -269.50 |
| EPS Diluted Continuous Ops | -46.06 | -65.68 | -117.88 | -165.88 | -269.33 |
| EPS Diluted Before Non-Recurring Items | -46.12 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,155 | $-8,015 | $-11,231 | $-10,544 | $-11,818 |